Oncology Data Advisor

The Digital Fingerprint: Accelerating Personalized Drug Discovery and Development at iLoF

Informações:

Synopsis

In this episode of Exploring Artificial Intelligence in Oncology, Dr. Waqas Haque sits down with Luis Valente, CEO and Co-Founder of iLoF, a digital health company pioneering a breakthrough AI platform to accelerate the future of personalized drug discovery and development.